Piribo: New publication announcement, The Pharmaceutical Market: Portugal

Portugal has a small pharmaceutical market, valued at US$4.1 billion, growing at an annual rate of 8.0%. Foreign manufacturers lead the market, although leading national producers include Hovione, Bial and Medinfar. The generic sector has considerably grown between January 2003 and September 2004, currently accounting for 7.9% of the pharmacy market value. Ratiopharm leads this sector, accounting for 32% of the total.

Pharmaceutical marketing applications (MA) considerably increased in 2003, of which around 60.1%, equal to 633, were undertaken via the national procedure. Granted MA applications via the national procedure accounted for over half of the total in 2003, equal to 434. Post-market surveillance has also increased in Portugal, with four regional pharmacovigilance centres working in parallel to a national centre since 2001. One of the main concerns, however, is how slow INFARMED is when processing applications.

The new reference price system (SPR - Sistema de Preos de Referncia) and prescription of medicines by ICD (International Common Denomination) were established in Portugal, by decrees published in December 2002. Since April 2004, reference prices and their respective homogenous groups need to be approved/updated every three months. In 2003 and 2004, packaging and labelling requirements were brought in line with the SPR.

These pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Contents
Background Data
Geography
Political overview
Economic Overview
Economic Indicators, 2004-2011
Population
Population by Region, 2003-2005
Population Forecasts, 2006-2011
Demographic Indicators
Demographic Indicators, 2000-2004
Mortality
Causes of Death, 2004
Causes of Death, 2001-2004
Cancer Deaths
Cancer Deaths by Main Primary Causes, 2002-2004
Morbidity
Notification of Infectious Diseases, 1990 - 2002
Reported AIDS Cases, 1990-2002
Number of Newly Diagnosed Cancers by Year of Diagnosis, 1989-2003</div></div>
Healthcare System
Organisation &amp;amp; Administration
Health Expenditure
Hospital Services
Ambulatory Care
Medical Personnel
Accessing The Pharmaceutical Market
Introduction
Regulatory Environment
Distribution Channels
Domestic Production
Dsm Bv


“The Pharmaceutical Market: Portugal” is available from Piribo. For more information go to: http://www.piribo.com/publications/temp/pharmaceutical_market_portugal.html

Piribo Product ID: ESP954

About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.